RESUMO
Fetal macrosomy represents a materno-fetal high-risk pathology in front of which obstetricians face diagnostic, therapeutic and prognostic problems. We report a retrospective analytical study of 400 deliveries of macrosomes brought together in the gynaecology and obstetrics C departement of the maternity center of Tunis over a period of 4 years from 1997 till 2001. The aim of our study is to stress on the materno-fetal risk factors of macrosomy. The frequency the macrosomy was of 7, 11%. The average maternal age was of 30, 9 years. Pathologies associated with pregnancy were dominated by gestational diabetes in 19% of cases and by toxemia in 17% of cases. The antecedents of big baby were noted in 23% of cases. Screening of macrosomy was based on excessive uterine height [>35 cm] found in 43 % of cases and near term ultrasounds, which suspected macrosomy in 21, 8% of the cases. Delivery was made naturally in 68 % of the cases, with instrumental help in 5, 25% of cases and by cesarian section in 32% of cases. The mean weight of macrosomes was of 4233g. Maternal complications were dominated by delivery hemorrage in 2% of cases and obstetrical trauma in 2, 75% of the cases. Fetal complications were dominated by shoulder dystocia in 2, 25% of the cases, respiratory distress 2, 75% of cases and hypoglycemia in 2% of the cases
RESUMO
In this study, Dpo-Provra [R] was evaluated in 930 women. It is a retrospective longitudinal bicentric study: We revealed the following The average age is 30,8 years. 66,6% the women have between 1 and 3 children. The nulliparous represent 17%. In 84,3%, it is the first used contraceptive method. The first injection was done in the post abortion in 65,3% of the cases. Pearl index is 0,46. Thus, the efficacy level is 99,54%. Amenorrhea is the most frequent trouble; its incidence within a year is 52,3%. It the first cause of abandon. The other troubles of the cycle disappear within 12 months. The acceptability is 34,8% year women